Home
About Vaxeal
Corporate
Management
Scientific advisory board
Science
Cancer Immunotherapies
Scientific Approach
Pipeline
Competitive advantage
Technology platforms
Collaborations
Health challenge
News & Trends
Contact us
Latest News
01
AUG
PEVIA Consortium Submits 1st Intermediate Report
Learn more...
By vaxeal Team
02
JUL
EUROPEAN BIOPHARMACEUTICAL ENTERPRISES ANNOUNCES CEO OF VAXEAL AS NEW PRESIDENT
Learn more...
By vaxeal Team
20
JUN
AHMED BOUZIDI GAVE A PRESENTATION AT THE INTERPAT GENERAL ASSEMBLY
Learn more...
By vaxeal Team
03
JAN
GEOVAX AND VAXEAL COLLABORATE ON CANCER IMMUNOTHERAPY PROGRAM
Learn more...
By vaxeal Team
05
OCT
The IMI-funded PEVIA Project Officially Kicked-off
Learn more...
By vaxeal Team
01
JUN
PEVIA consortium created by VAXEAL has received a grant of 6.2M€ from the Innovative Medicines Initiative (IMI)
Learn more...
By vaxeal Team
16
APR
AHMED BOUZIDI, PANELIST AT THE 4th ANNUAL EAPM PRESIDENCY CONFERENCE
Learn more...
By vaxeal Team
28
MAR
VAXEAL PARTICIPATED IN THE IPROVE ROADMAP
Learn more...
By vaxeal Team
12
DEC
THE MEMBERS OF THE ANR-13-RPIB-0004 CONSORTIUM SUBMITTED THE FIRST INTERMEDIATE REPORT ON SVX-1
Learn more...
By vaxeal Team